PON2 (paraoxonase-2) is a ubiquitously expressed antioxidative protein which is largely found in the ER (endoplasmic reticulum). Addressing the cytoprotective functions of PON2, we observed that PON2 overexpression provided significant resistance to ERstress-induced caspase 3 activation when the ER stress was induced by interference with protein modification (by tunicamycin or dithiothreitol), but not when ER stress was induced by disturbance of Ca 2+ homoeostasis (by thapsigargin or A23187). When analysing the underlying molecular events, we found an activation of the PON2 promoter in response to all tested ER-stress-inducing stimuli. However, only tunicamycin and dithiothreitol resulted in increased PON2 mRNA and protein levels. In contrast, when ER stress was caused by thapsigargin or A23187, we observed a Ca 2+ -dependent active degradation of PON2 mRNA, elicited by its 5 -untranslated region. In addition, thapsigargin and A23187 also induced PON2 protein degradation by a Ca 2+ -dependent calpain-mediated mechanism. Thus we provide evidence that independent mechanisms mediate the degradation of PON2 mRNA and protein after disturbance of Ca 2+ homoeostasis. Furthermore, because Ca 2+ -disturbance induces ER stress, but abrogates the otherwise protective function of PON2 against ER-stress-induced apoptosis, we propose that the underlying cause of ER stress determines the efficacy of putative cellular defence mechanisms.
INTRODUCTION
Upon synthesis, all proteins destined for transmembrane insertion or secretion translocate to the ER (endoplasmic reticulum). The ER is the site of protein amino-glycosylation, disulfide bond formation and proper folding of nascent proteins. In order to assist these processes, cells express molecular chaperones such as calnexin, GRP78 (glucose-regulated protein of 78 kDa) [also known as BiP (immunoglobulin heavy-chain-binding protein)] and PDI (protein disulfide-isomerase). Whereas formation and isomerization of disulfide bonds are catalysed by PDI [1] , calnexin governs proper protein structure by retaining incorrectly folded proteins in the ER [2] . Ample evidence indicates that various stimuli, e.g. deprivation of amino acids, disturbance of glucose or Ca 2+ homoeostasis or redox potential, may interfere with protein maturation, which induces ER stress via the accumulation of unfolded proteins. This activates a conserved intrinsic stress response known as the UPR (unfolded protein response) pathway. The UPR consists of three different orchestrated branches initiated by activation of ER stress transducers IRE1 (inositol-requiring protein 1), PERK [PKR (double-stranded-RNA-dependent protein kinase)-like ER kinase] and ATF6 (activating transcription factor-6); these enable cellular responses ranging from stress relief to ER remodelling, protein degradation, autophagy and apoptosis [3] . A key mediator of the UPR is GRP78. Although still under debate, one model of how ER stress is sensed suggests that, under unstressed conditions, GRP78 binds to IRE1, PERK and ATF6 to keep them in an inactive state. Upon stress, however, the ER chaperone GRP78 is attracted by and binds to unfolded proteins, which results in a loss of interaction of GRP78 with IRE1, PERK and ATF6 [4, 5] . This activates these integral membrane proteins that thereby sense the folding status in the ER lumen and link this information to cytosolic events. As such, IRE1 performs unusual splicing of XBP1 (X-box-binding protein-1) mRNA, PERK phosphorylates eIF2α (eukaryotic initiation factor 2α) protein and ATF6 is proteolytically processed in order to release a soluble cytosolic portion that acts as a transcription factor [6] . As a consequence, general translation is diminished and gene expression is altered rapidly in order to alleviate stress or undergo apoptosis.
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understanding of underlying molecular mechanisms is mandatory, as it determines UPR-induced gene expression and regulation of molecular stabilities, as well as pro-and anti-apoptotic factors. We described recently that another cellular enzyme, PON (paraoxonase) 2 is involved in ER stress [18] . The PON family of proteins consists of three highly similar enzymes, PON1, PON2 and PON3 [19] , with characterized enzymatic activities [20, 21] . Although it is known that PON2 plays a dominant role in the inactivation of certain lactone(s) involved in quorum sensing of Pseudomonas aeruginosa [22, 23] , natural endogenous substrates remain relatively elusive. In the case of PON2, we reported the existence of two distinct glycosylated splice variants [18] . In vivo studies using transgenic and/or deficient mice revealed anti-atherogenic properties of all three PONs [24] [25] [26] [27] . In accordance, we and others reported that PON2 significantly reduced intracellular oxidative stress [18, 28] . Although regulation of PON2 expression remained largely enigmatic, it is known that PON2 expression is induced by both ER stress [18] and oxidative stress [29] and appears to be regulated, at least in part, by PPARγ (peroxisome-proliferator-activated receptor γ ) and AP1 (activator protein 1) pathway activation [30] . Prompted by the observation that PON2 overexpression rendered endothelial cells significantly more tolerant to ER-stress-induced apoptosis (i.e. caspase 3 activation), which was opposed after down-regulation of PON2 [18] , we asked as to whether PON2 was generally protective against ER-stress-induced apoptosis. In the present paper, we report that the protective and anti-apoptotic effect of PON2 was not a general phenomenon; it was absent when the ER stress was induced by Ca 2+ deregulation. The present study was designed to uncover the underlying molecular events leading to a loss of protection by PON2 under specific ER stress conditions.
EXPERIMENTAL

Cultivation of EA.hy 926 cells and UPR induction
Human endothelial EA.hy 926 cells were cultured in DMEM (Dulbecco's modified Eagle's medium) without Phenol Red (Sigma) containing sodium pyruvate (PAA Laboratories), antibiotics penicillin/streptomycin, HAT (hypoxanthine/aminopterin/ thymidine) supplement, GlutaMAX TM (Invitrogen) and 10 % (v/v) fetal calf serum (Perbio). Cells were cultured at 37
• C in a humidified atmosphere under 10 % CO 2 . Medium for cultivation of EA.hy 926 cells stably overexpressing PON2-iso1 (PON2 isoform 1)-GFP (green fluorescent protein) or PON2-iso1-HA (haemagglutinin) [18] contained geneticin (300 μg/ml) (PAA Laboratories) in addition. Cells were confluently seeded in 96-well plates (2.0 × 10 4 /well) or 24-well plates (10 5 /well). The next day, DTT (dithiothreitol) (in water), tunicamycin (Sigma), thapsigargin (Invitrogen), A23187 (Sigma) or solvent control DMSO was added to fresh culture medium (see the Figure legends for concentrations and durations of treatment). Maximum DMSO concentration did not exceed 0.5 %. Efficient UPR induction was verified in every experiment by confirming enhanced expression of GRP78 mRNA and/or protein.
Inhibitors, cell lysis and Western blotting
Cells were seeded and treated as outlined above. Unless indicated otherwise, the following inhibitors (or solvent control) were supplemented for 1 h in complete growth medium before addition of UPR-inducing compounds (all from Sigma, unless stated otherwise): proteasome inhibitors lactacystin (10-50 μM) (Cayman Chemicals) and MG132 (10 μM); autophagy inhibitor 3-MA (3-methyladenine) ( • C. Protein content was determined using the BCA (bicinchoninic acid) protein assay reagent (Pierce). Western blotting was performed as described previously [18] . The following primary antibodies (all anti-human) were used: mouse monoclonal anti-α-tubulin (Ab-2 DM1a; Dianova), goat anti-GRP78 (C-20; Santa Cruz) and rabbit-anti-PON2 [18] .
Cloning of the PON2 5 -UTR (untranslated region)
Previously, we described the generation of a pGL4.10 plasmid (Promega) containing genomic DNA of the PON2 gene ranging from 2249 bp upstream of the 5 -end to position + 112 [18] . This plasmid was digested with restriction enzyme NcoI, which cuts out a 147bp fragment (containing parts of exon 1, intron 1/2 and some vector backbone); re-ligation of the larger fragment (6444 bp) results in a plasmid harbouring the PON2 promoter fragment (− 2249 to − 1), followed directly by the putative PON2 5 -UTR and the firefly luciferase gene. Thus the putative PON2 5 -UTR was cloned based on the Genatlas gene database; its sequence consisted of 31 bp: 5 -GGAGCGAGG-CAGCGCGCCCGGCTCCCGCGCC-3 . Because this sequence was cloned according to public database entries, it may not represent the complete PON2 5 -UTR.
Cloning of the PON2 3 -UTR by RACE (rapid amplification of cDNA ends) Using EA.hy 926 total RNA, PON2 mRNA 3 -UTR was amplified by 3 -RACE with primers 5 -GAGAGATCTAGACTCGTCAGA-GGTTCTCCGCATCCAG-3 and 5 -CATCCTGGTCGAGCTG-GGGCCGGCCTTTTTTTTTTTTTTTTTTTTTTTTTG-3 with the Superscript-II RT (reverse transcription)-PCR system (Invitrogen) according to the manufacturer's instructions. Amplified DNA was gel-purified, blunt ends were generated using Klenow fragment, and the DNA inserted into zeroblunt pCR4-TOPO plasmid (Invitrogen) and sequenced. The amplified sequence contains the 3 -UTR and a limited base pair number of the coding sequence. From this plasmid, the 3 -UTR was amplified by PCR using the same reverse primer as before together with the sense primer 5 -GACAGACATCTAGA-ATTGTACTTTTGGCATGAAAGTGCG-3 . The amplified 3 -UTR was inserted into the plasmid pGL4-PON2-promoter [18] C-terminal to the luciferase gene by standard cloning procedures using restriction enzymes FseI and XbaI followed by sequencing. At the indicated times, total RNA was extracted from EA.hy 926 cells cultured in 24-well plates using E.Z.N.A. total RNA kit (Omega Bio-tek) according to the manufacturer's instructions. Then, 80 ng of RNA was used for cDNA generation using a High Capacity cDNA RT kit (Applied Biosystems) according to the manufacturer's instructions. Finally, RNA expression levels were quantitatively analysed using 2 μl of cDNA, 1 unit of Taq polymerase (PeqLab), 0.4 μl of 10 mM dNTPs and 2 μl of primer per 20 μl reaction volume in a Bio-Rad iCycler. Pre-designed validated Taqman primers for detection of PON2 or GRP78 were purchased from Applied Biosystems. Additionally, the following Taqman primers (synthesized by MWG Biotech) were used: for spliced XBP1, 5 -GGAG-TTAAGACAGCGCTTG-3 (sense), 5 -GCACCTGCTGCGGA-CTC-3 (antisense) and 5 -GAAGCCAAGGGGAATGAAGT-3 (probe); for GAPDH (glyceraldehyde-3-phosphate dehydrogenase), 5 -CAACAGCCTCAAGATCATCAGC-3 (sense), 5 -TGGCATGGACTGTGGTCATGAG-3 (antisense) and 5 -CCT-GGCCAAGGTCATCCATGACAAC-3 (probe); for EGFP (enhanced GFP), 5 -CTGACCCTGAAGTTCATCTGC-3 (sense), 5 -AAGTCGTGCTGCTTCATGTG-3 (antisense) and 5 -TCGT-GACCACCCTGACCTAC-3 (probe); for firefly luciferase, 5 -TGCAAAAGATCCTCAACGTG-3 (sense), 5 -AATGGGA-AGTCACGAAGGTG-3 (antisense) and 5 -AAGACCGACTA-CCAGGGCTT-3 (probe); for Renilla luciferase, 5 -ATTGGTAT-GGGCAAATCAGG-3 (sense), 5 -GGCCGACAAAAATGA-TCTTC-3 (antisense) and 5 -TCTTACTGCATGGTTTGAA-CTTCT-3 (probe). qRT-PCR was performed as described previously [18] . All mRNA levels were normalized to GAPDH mRNA (or Renilla luciferase mRNA where indicated) from the same samples and calculated by the 2 − Ct method. When analysing the function of PON2 mRNA UTRs, cells were co-transfected with a plasmid allowing for constitutive Renilla luciferase expression and the indicated pGL4-PON2-promoter plasmids (including the 3 -or 5 -UTR). After the specific treatment, RNA was prepared as above, but additional extensive DNase I on-column digestion (Omega Bio-tek) was performed. Principally, this method is somewhat susceptible to unwanted amplification of remaining plasmid DNA in RNA preparations. Therefore we controlled effective plasmid digestion by including RNA preparations without DNase I digestion in every experiment. In subsequent qRT-PCR analyses, these differed by a factor of >20 (results not shown).
Software, statistics and image acquisition
Device-specific software provided by the suppliers was used. In addition, GraphPad Prism software was used for any calculations of collected data, for non-linear regression curve fitting or statistical evaluation using one-way ANOVA with Bonferroni's multiple comparisons post-test (see Figure legends) . P < 0.05 was considered significant. Adobe Photoshop software was used for image acquisition of scanned Western blots. If any adjustment was necessary, only brightness and/or contrast was changed and adjusted simultaneously for all lanes and areas of any blot.
Other materials and methods
All other relevant materials such as plasmids, promoter reporter analyses and caspase 3/7 activity determination have been described recently [18] .
RESULTS
PON2 protects against ER-stress-induced apoptosis unless ER stress is caused by disturbance of Ca 2+ homoeostasis
Prolonged ER stress can induce apoptosis, which can be monitored by the activity of executioner caspase 3. We determined . Caspase 3/7 activation in PON2-iso1-GFPor PON2-iso1-HA-overexpressing cells was significantly lower than in naïve EA.hy 926 cells with concentrations equal to or higher than 10 mM DTT or 1 μg/ml tunicamycin (P < 0.05; P < 0.001 respectively).
the effect of PON2 overexpression on caspase 3/7 activation in response to a 16 h treatment with various concentrations of different ER-stress-inducing compounds, namely tunicamycin, DTT or thapsigargin. These induce ER stress via distinct mechanisms: DTT obliterates protein structures, tunicamycin interferes with protein amino-glycosylation, and thapsigargin disturbs cellular Ca 2+ homoeostasis. As a control, we first determined the maximum caspase 3/7 activation by treating naïve EA.hy 926 cells with proapoptotic staurosporine ( Figure 1A ). Within the concentrations tested, 0.3 μM staurosporine resulted in the highest (approx. 5-fold) stimulation. We then treated EA.hy 926 cells with increasing concentrations of DTT and observed concentrationdependent caspase 3/7 activation ( Figure 1B ). In cells stably overexpressing PON2-iso1-GFP or PON2-iso1-HA, maximum DTT-induced caspase 3/7 activation was markedly reduced. Similar results were obtained with tunicamycin ( Figure 1C) . Here, PON2-overexpressing cells showed only very limited caspase 3 activation. However, different results were obtained for thapsigargin-induced caspase 3 activation. PON2 overexpression somewhat decreased the potency of thapsigargin to induce caspase 3/7 activation, but the maximum effect was not significantly reduced ( Figure 1D ).
Stimulators of ER stress enhance PON2 promoter activity
Addressing underlying molecular events causing loss of protection of PON2 against thapsigargin-, but not tunicamycinor DTT-induced caspase 3/7 activation, we analysed the relative alterations in PON2 gene expression caused by the tested compounds. We described recently the generation of a plasmid harbouring a firefly luciferase gene under the expressional control of a PON2 promoter fragment (pGL4-PON2-promoter, corresponding to region − 2249 to − 1), which was used for reporter gene analyses [18] . Within this promoter fragment, sequences with high homology with ER-stress-responsive cisacting elements can be found, such as ERSE (ER stress element)-like sequence [31] and the UPRE (UPR element) [32] . This plasmid was used to evaluate the effect of different UPR-inducing compounds on PON2 promoter activation. Transiently transfected human endothelial EA.hy 926 cells were treated for 16 h with various concentrations of DTT, tunicamycin or thapsigargin. A concentration-dependent increase in promoter activity was observed with all three substances (Figure 2) . With the highest concentrations tested, a 5-fold (tunicamycin; Figure 2B ) to 9-fold (DTT, thapsigargin; Figures 2A and 2C ) enhancement was observed. Interestingly, there was no decline in promoter activity even with concentrations that evidently induced pro-apoptotic executioner caspase 3 (see Figure 1) . Non-specific induction of the PON2 promoter by serum components was excluded by the similar induction levels observed in the absence or presence of serum ( Figure 2D ).
Tunicamycin and DTT induce, whereas thapsigargin causes a decline in, PON2 mRNA expression
We next determined the effect of the UPR inducers on endogenous PON2 mRNA levels. EA.hy 926 cells were treated with constant concentrations of DTT (2.5 mM) or tunicamycin (1 μg/ml) and samples were taken at different times for PON2 mRNA quantification by qRT-PCR. UPR induction was verified by significantly increased levels of endogenous GRP78 mRNA (results not shown), whose induction is considered to be characteristic of ER stress. Figure 3(A) shows that DTT led to a moderate increase (∼ 180 %) of endogenous PON2 mRNA in a time-dependent fashion. Similarly, tunicamycin treatment caused enhanced PON2 mRNA expression ( Figure 3B ). Here, PON2 mRNA levels increased approx. 3-fold after 6 h. Upon exposure to thapsigargin, however, the reverse result was obtained. Specifically, we observed both a time-and concentrationdependent decline in PON2 mRNA levels after thapsigargin treatment ( Figures 3C and 3D respectively) . Hence, although DTT, tunicamycin and thapsigargin equally induce both the UPR pathway and PON2 promoter, they show opposite effects on endogenous PON2 mRNA levels.
Principally, a thapsigargin-induced decrease in PON2 mRNA levels may result from both a discontinued transcription and an active degradation. The latter was tested by analysing PON2 mRNA stability. To this end, cells were pre-treated with lower non-cytotoxic concentrations of DTT (2.5 mM), tunicamycin (0.5 μg/ml) or thapsigargin (1 nM) for 4 h to induce the UPR, followed by inhibition of RNA synthesis by addition of DRB. In parallel, basal PON2 mRNA decay in indigenous EA.hy 926 cells was monitored. These analyses revealed a surprisingly long halflife of PON2 mRNA. Even 24 h after inhibition of RNA synthesis by DRB, on average 70 % of PON2 mRNA remained present (Figure 4) . Similar results were obtained using actinomycin D (see below). This is in agreement with our observation of a relatively long half-life (approx. 2-3 days) of PON2 protein, Figures 4A and 4B respectively) did not significantly change the decay of endogenous PON2 mRNA. UPR induction by thapsigargin, however, resulted in a significantly faster decay of PON2 mRNA ( Figure 4C ). Already at the first time analysed (4 h), PON2 mRNA was degraded by approx. 25 %, whereas no significant decay was observed at this time under the other conditions tested. Thus, in contrast with DTT or tunicamycin, thapsigargin treatment of EA.hy 926 cells induced an active degradation of PON2 mRNA.
Disturbed Ca
2+ homoeostasis, but not the secondary activation of the UPR pathway, causes PON2 mRNA decay Thapsigargin blocks the SERCA (sarcoplasmic/endoplasmic reticulum Ca 2+ -ATPase), which depletes ER calcium storage thereby causing ER stress. We next investigated whether the observed PON2 mRNA decay upon thapsigargin treatment results from the primary stimulus, namely deregulated intracellular Ca 2+ signalling, or from a secondary thapsigargin-specific UPR induction. For this purpose, naïve EA.hy 926 cells EA.hy 926 cells were left untreated (control) or were treated for 16 h with thapsigargin (Thapsi; 10 nM) (A-C), Ca 2+ ionophore A23187 (10 μM) (D-F), the intracellular Ca 2+ -chelator BAPTA/AM (BAPTA; 10 μM; 1 h pre-treatment where indicated) or combinations thereof (A-F). Then, cells were lysed, RNA was prepared, and mRNA levels of PON2 (A and D), GRP78 (B and E) or sXBP1 (C and F) were monitored by qRT-PCR. (G and H) EA.hy 926 cells were transfected with plasmids pGL4-PON2-promoter, pGL4-PON2-promoter + 5 -UTR or pGL4-PON2-promoter+3 -UTR. A plasmid for constitutive expression of Renilla luciferase was co-transfected. Cells were treated with DMSO (0.1 %; solvent control), thapsigargin (10 nM) (G) or tunicamycin (10 μg/ml) (H) for 16 h. Then, total RNA was prepared with concomitant DNase I digestion (see the Experimental section), and firefly luciferase mRNA levels were determined by qRT-PCR. These were normalized to Renilla luciferase mRNA levels to control for transfection efficiencies. Basal expression was comparable for all constructs and was independent of the addition of 5 -or 3 -UTRs (not shown). (J) EA.hy 926 cells stably overexpressing PON2-GFP were left untreated or were treated with actinomycin D (Actino; 5 μg/ml) alone or in combination with thapsigargin (Thapsi; 10 nM) for 16 h. Subsequently, total RNA was prepared and PON2-GFP mRNA levels were determined by qRT-PCR. Results are means + − S.E.M. (n = 4-9). Differences were tested for statistical significance using one-way ANOVA and Bonferroni's multiple comparisons post-test: n.s., not significant; * P < 0.05; * * P < 0.01; * * * P < 0.001.
were treated for 16 h with thapsigargin (10 nM) or the potent cytosolic Ca 2+ -chelating compound BAPTA/AM (10 μM), or combinations thereof. Although BAPTA/AM treatment by itself resulted in somewhat reduced PON2 mRNA levels, it clearly inhibited the thapsigargin-induced degradation of PON2 mRNA ( Figure 5A ). The UPR pathway was still activated in the thapsigargin + BAPTA/AM-treated samples as was evident by more than 15-and 11-fold increases in GRP78 mRNA and sXBP1 (spliced XBP1) mRNA respectively ( Figures 5B and 5C ). This suggests that PON2 mRNA degradation results from deregulated Ca 2+ signalling rather than the UPR. Therefore we explored whether a mechanistically different disturbance of intracellular Ca 2+ homoeostasis results in similar effects. Indeed, EA.hy 926 cells treated with the calcium ionophore A23187 showed significantly reduced PON2 mRNA levels, which could be inhibited by BAPTA/AM ( Figure 5D ). Similarly to thapsigargin, A23187 also produced a marked enhancement of GRP78 and sXBP1 mRNA levels, even in the presence of BAPTA/AM (more than 16-and 18-fold respectively; Figures 5E and 5F).
Next we examined whether the PON2 mRNA Ca 2+ -responsive element is located in the UTRs or, for example, the coding sequence. To this end, we performed 3 -RACE experiments and cloned the 3 -UTR of PON2, as well as the 32-bp-long 5 -UTR (according to public database entries) into the above-mentioned pGL4-PON2-promoter plasmid. As a result, this plasmid was modified so that the encoded firefly luciferase mRNA was Nor C-terminally fused to the 5 -or 3 -UTR of endogenous PON2 mRNA respectively. Basal expression was comparable for all constructs and was independent of the addition of 5 -or 3 -UTRs (results not shown). As shown in Figure 5 (G), thapsigargin treatment enhanced PON2 promoter activity and resulted in a marked increase of firefly luciferase mRNA (in agreement with firefly luciferase activity; Figure 2C ). However, after PON2 5 -UTR was fused to firefly luciferase mRNA, thapsigargin caused pronounced destabilization of this unrelated mRNA ( Figure 5G) . The 3 -UTR of PON2 showed no such effect ( Figure 5G) . Also, the Ca 2+ -independent stressor tunicamycin did not induce decay of the firefly luciferase mRNA independent of the addition of the PON2 5 -or 3 -UTR ( Figure 5H ).
Thus we presumed that the Ca 2+ -responsive element of endogenous PON2 mRNA is located in its 5 -UTR. In agreement with this assumption, firefly luciferase mRNA levels in thapsigargintreated cells overexpressing the 5 -UTR construct were reduced to less than control levels (∼ 80 % in thapsigargin treated relative to untreated cells; Figure 5G ). As further evidence for the occurrence of an Ca 2+ -responsive element in the 5 -UTR of PON2 mRNA, we showed that thapsigargin treatment did not cause degradation of overexpressed PON2-GFP mRNA ( Figure 5J ), which solely contains the PON2-coding sequence without UTRs.
DTT and tunicamycin enhance PON2 protein levels, whereas disturbed Ca 2+ homoeostasis causes its degradation
To test whether disturbed Ca 2+ homoeostasis also results in PON2 protein degradation, similar experiments as above were performed, and protein levels were controlled by Western blotting. As shown recently [18] and in Figure 6 (A), DTT (2.5 mM) treatment of EA.hy 926 cells resulted in a moderate timedependent increase in PON2 protein expression. UPR activation was verified by probing for GRP78 (results not shown). Similarly, tunicamycin treatment caused enhanced PON2 protein expression in a concentration-and time-dependent manner (Figures 6B and 6C respectively). Since both isoforms of PON2 are glycosylated, a process which is inhibited by tunicamycin, newly synthesized PON2 isoforms 1 and 2 appear with lower apparent molecular masses. De novo synthesis of these isoforms is indicated by the fact that their emergence is prevented by cycloheximide ( Figure 6C ). Importantly, no degradation of PON2 protein was observed even with concentrations of tunicamycin that strongly activate pro-apoptotic caspase 3/7 ( Figure 1C) .
In contrast, thapsigargin treatment resulted in a concentrationdependent degradation of PON2 protein ( Figure 7A ). This was partially inhibited by pre-treatment with BAPTA/AM ( Figure 7B ). Similarly to the results obtained for PON2 mRNA, A23187 mimicked the thapsigargin-mediated effects on PON2 protein; A23187 treatment also caused PON2 degradation, which was mostly prevented by BAPTA/AM (Figures 7C and 7D) . Finally, we investigated the underlying mechanism of this active PON2 degradation. Thapsigargin-or A23187-mediated increases in cytosolic Ca 2+ concentrations may give rise to, for example, proteasomal degradation of proteins, calpain protease activation or autophagy. In order to distinguish between these possibilities, EA.hy 926 cells were treated for 16 h with 10 nM thapsigargin alone or together with inhibitors of proteasome activity MG132 (10 μM) (results not shown) and lactacystin (50 μM), calpain inhibitor-I (ALLN, 5 μM) or an inhibitor of autophagy (3-MA, 5 μM). As shown in Figure 7 (E), thapsigargin-induced decay of PON2 did not result from proteasomal activity or autophagy, because the well-known and potent inhibitors lactacystin and 3-MA did not prevent PON2 degradation. In contrast, we have shown that PON2 protein is subject to Ca 2+ -activated calpain protease activity, because the calpain inhibitor-I ALLN inhibited thapsigargin-induced PON2 decay. In summary, PON2 protein stability negatively correlates with increased cytosolic Ca 2+ concentrations and calpain activation. Similarly to endogenous PON2, this also applies to stably overexpressed PON2-GFP, which is degraded upon thapsigargin exposure in a timedependent manner ( Figures 7F and 7G respectively) . Thus the degradation of both endogenous and overexpressed PON2 in response to Ca 2+ disturbances elucidates the cause of lack of protection by PON2 overexpression against thapsigargininduced apoptosis. To demonstrate the close correlation between thapsigargin-induced PON2 mRNA and protein degradation on the one hand, and caspase 3/7 activation on the other, these parameters were plotted on one graph ( Figure 7H ). 
DISCUSSION
ER stress is critically involved in the pathogenesis of diseases such as diabetes [10] or neurodegenerative disorders [7] . In atherogenesis, enhanced uptake of free cholesterol by macrophages has been shown to induce ER stress [33] . Owing to the central position of the ER and the UPR, there is significant interest in factors modulating the cellular pro-and anti-apoptotic response to ER stress. Since the underlying cause of ER stress appears to be critical for the cellular response, we investigated whether the recently discovered anti-apoptotic function of PON2 was applicable for several forms of ER stress or whether it was dependent on the inducing stimulus and whether different causes of the stress similarly affected PON2 gene expression.
Stable overexpression of PON2 decreased caspase 3 activation stimulated by DTT or tunicamycin, but not that stimulated by thapsigargin. Most probably, this is due to the fact that deregulation of cytosolic Ca 2+ -levels in response to thapsigargin or A23187 caused a rapid degradation of both endogenous and even overexpressed PON2. Because even strongly pro-apoptotic concentrations of tunicamycin did not result in PON2 degradation, this implies that tunicamycin-induced apoptosis does not elicit a secondary rise in cytosolic Ca 2+ , at least not to the extent caused by low concentrations of thapsigargin or A23187. Alternatively, our data could suggest that the protective effect of PON2 lies upstream of caspase 3 and that PON2 does not, for example, interfere with caspase 3 activation directly. In addition, it appears unlikely that UPR-accompanying ROS production is the underlying common pro-apoptotic mechanism, as this would probably be mostly decreased by overexpression of antioxidative PON2. Moreover, it may suggest that PON2 has different effects on the pro-apoptotic pathways activated by the tested compounds. Thapsigargin mediates apoptosis by mitochondrial caspase-dependent death cascades, Ca 2+ -dependent anti-apoptotic phosphoinositide 3-kinase/MAPK (mitogen-activated protein kinase) activation [34] and depends on enhanced nitric oxide synthase activity [35] . Tunicamycin-induced cell death, in contrast, is facilitated by ERspecific apoptosis pathways, i.e. by ER-resident protein calnexin [36] or caspase 2/9 activation [37] . Owing to its ER localization [18, 38] , PON2 may primarily interfere with ER-derived apoptotic pathways. In line with this, neither PON2 overexpression nor knockdown altered nitric oxide production in EA.hy 926 cells (M. Krüger and S. Horke, unpublished work), which is considered essential for thapsigargin-induced apoptosis [35] .
When addressing ER stress-induced alterations in PON2 gene expression, we found that a heterogeneous group of compounds whose common denominator is the induction of ER stress all stimulated PON2 promoter activity. Provided the PON2 promoter 2249 bp fragment contains all of the relevant regulatory sites, our data indicate that transcriptional activation of UPR-responsive genes is the consequence of a secondary UPR pathway activation and is independent of the UPR-inducing stimulus. ER-stressresponsive promoter elements such as ERSE, ERSE2, UPRE or others are not assigned to specific forms of stress (e.g. disturbed Ca 2+ homoeostasis compared with hindered protein modification). PON2 induction thus differs from the UPR-mediated induction of upstream ER-stress-responsive transcriptional activators such as ATF6 and XBP1, which appears to be stimulus-specific [39] . Additionally, ER stress transducers such as IRE1, PERK, ATF6 and XBP1 are activated with different time kinetics in order to meet cellular requirements for protein refolding/degradation or apoptosis [40, 41] .
At the level of mRNA turnover and/or translation, however, mechanism(s) evidently exist that can distinguish between DTT-, tunicamycin-, thapsigargin-and A23187-induced ER stress. These mechanism(s) may sense whether the increased expression of a specific protein is beneficial for stress relief and may regulate the mRNA/protein stability accordingly. This is in line with a global profiling of ER-stress-regulated mRNAs, where clear differences were found between thapsigargin or tunicamycin treatment of the same cells [42] . In the present study, all ERstress-inducing compounds tested resulted in a transcriptional activation of the PON2 gene. As expected, DTT and tunicamycin moderately increased PON2 mRNA and protein levels. In contrast, thapsigargin and A23187 produced a pronounced degradation of endogenous PON2 mRNA and protein. It is currently unclear which RNase activity (or other destabilizing mechanism) mediates the decay of PON2 mRNA. One candidate protein could be IRE1, which possesses RNase activity and was found recently to mediate the ER-stress-induced degradation of specific mRNAs in Drosophila [43] . IRE1 activation in our experimental setup was evident by markedly increased levels of spliced XBP1 mRNA. However, because BAPTA/AM prevented PON2 mRNA degradation, but not UPR induction or IRE1 activation, it appears unlikely that IRE1 fulfils this function in our model. Rather, increased cytosolic Ca 2+ -levels may activate mechanisms destabilizing PON2 mRNA. Ca 2+ is known to regulate mRNA stability through stabilizing or destabilizing proteins such as HuR or AUF-1 [ARE (AU-rich element)/poly(U)-binding/degradation factor 1] [44] . Interestingly, these proteins mostly act on UTRs, which is in line with our finding that Ca 2+ -induced PON2 mRNA decay depends on the 5 -UTR. Alternatively, Ca 2+ -stimulated RNase L [45] may represent a mechanism for PON2 mRNA decay. In contrast with PON2, it has been shown recently that ER stress, rather than cytosolic Ca 2+ , up-regulated HIF-1α (hypoxia-inducible factor 1α) mRNA [46] . In this context, it is to be noted that the PON2 mRNA 5 -UTR mediated the degradation of an unrelated (firefly luciferase) mRNA upon cytosolic Ca 2+ -increase; however, this effect was less pronounced when compared with results obtained for the Ca 2+ -induced degradation of endogenous PON2 mRNA. Thus one may speculate that additional sequences and/or structures found in the native PON2 mRNA may augment the destabilizing effect of the 5 -UTR upon cytosolic Ca 2+ increase. PON2 is a long-lived and stable protein (see Figure 6C) . Nevertheless, thapsigargin (and also Ca 2+ ionophore A23187) stimulated an active, rapid and calpain-mediated degradation of this protein (Figure 7 ). This is in agreement with the finding that an increase in intracellular Ca 2+ can be a potent activator of cytoplasmic proteases, thereby contributing to cell death [47] . To our knowledge, it is unknown whether (patho)physiological settings exist in which Ca 2+ -stimulated down-regulation of PON2 is observed. Given that PON2 protects cells from apoptosis (at least under some ER stress conditions), its decay upon Ca 2+ disturbance may contribute to the deleterious effects associated with various pathophysiological situations. Examples could include ischaemia, which perturbs Ca 2+ homoeostasis and activates calpains [48] , or the effects of oxysterols, which lead to increased cytosolic Ca 2+ levels and endothelial cell death [49] . Therefore it is mandatory to unravel the anti-apoptotic mechanism of PON2 and to explore whether this is a general phenomenon or restricted to the UPR.
We present several pieces of evidence indicating that two independent mechanisms mediate the degradation of PON2 mRNA and the destabilization of PON2 protein following disturbance of Ca 2+ homoeostasis. (i) PON2 protein is very stable; protein levels were unchanged 24 h after actinomycin D or 32 h after cycloheximide treatment ( Figures 7F and 6C respectively). Given this protein stability, an accelerated decay of PON2 mRNA in response to thapsigargin or A23187 cannot explain the parallel decay of PON2 protein (down to 42 % after 16 h; Figure 7F ). (ii) PON2-specific siRNA results in a 90 % reduction of PON2 mRNA after 1 day, but PON2 protein is not reduced before 3 days (results not shown). (iii) PON2 protein degradation occurs independent of the mRNA's 5 -UTR, because PON2-GFP protein is degraded after Ca 2+ disturbance, although the PON2-GFP mRNA lacks any UTR. (iv) We show that calpain proteases mediate Ca 2+ -stimulated PON2 protein decay. Taken together, our findings suggest that UPR-induced activation of the PON2 promoter is a relatively non-specific effect independent of the inducing stimulus. In contrast, the subsequent regulation of PON2 mRNA and protein stability seems to be specific for the stress-inducing mechanism(s). Increases in cytosolic Ca 2+ -concentrations lead to rapid degradation of both PON2 mRNA and protein by separate, unrelated, mechanisms. We thus demonstrate that the mechanisms causing ER stress are of major importance for PON2 regulation and its protective function against ER-stress-induced caspase 3 activation. 
